Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)

Clinical trial NCT06390956 · RECRUITING

Trial details

NCT number: NCT06390956
Sponsor: University of Utah
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Marginal Zone Lymphoma

Start date: 2025-02-20
Primary completion: 2031-12-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.